Treating CLL with novel therapies

    Professor Peter Hillmen

    Advances in Immuno-Oncology

    Dr Robert Weinkove, Consultant Haematologist at Wellington Blood and Cancer Centre and Clinical Director at Malaghan Institute of Medical Research introduces the topic of immuno-oncology.  He discusses current and emerging classes of cancer immunotherapies and gives an overview of their mechanisms of action, current place in treatment and recognition of adverse effects in primary care.
     

    Immunotherapy for advanced melanoma: clinical outcomes

    Dr Rosalie Stephens is a medical oncologist at Auckland Hospital with a special interest in treating melanoma and is a Trustee on the board of Melanoma NZ. In this video podcast Dr Stephens describes the clinical outcomes achieved with immunotherapy for advanced melanoma.

    The importance of using tools beyond lifestyle in managing obesity

    Goodfellow Symposium
    Sunday 25 March 2018

    Presentation by:

    Professor John Dixon, Head of clinical obesity research at the Baker Heart and Diabetes Institute in Melbourne, Australia.

    In this Breakfast Symposium, Professor John Dixon focused on the importance of tools such as pharmacotherapy, meal replacements and bariatric surgery, as lifestyle enablers, in the management of obesity, a disease he notes should be approached in the same manner as other chronic illnesses.

    IBD in Primary Care – Practical Management Tips

    GPCME 2018 - Rotorua
    Saturday June 9, 2018

    Presentation by:
    Dr David Rowbotham
    Consultant Gastroenterologist, Department of Gastroenterology and Hepatology, Auckland Hospital

    In this workshop held at GPCME 2018, Dr David Rowbotham presented tips for primary care clinicians on the best approaches to managing IBD patients in everyday practice.  He also discussed some novel therapies, stopping treatment and the IBD clinical trials taking place at the Auckland District Health Board.
     
    The video production for this presentation was funded by Emerge Health.

    Breakfast Session - Shared Care of the IBD Patient

    GPCME 2018 - Rotorua
    Sunday  June 10, 2018

    Presentations by:
    Drs Rick Stein and Ali Jafer (Consultant Gastroenterologists)
    Phoebe Wu and Jacqui Fletcher (IBD Nurses)

    In this Breakfast Session held at GPCME 2018, Dr Rick Stein discussed the growing burden of IBD in NZ.
     
    Dr Ali Jafer and Phoebe Wu also presented on the value of and models for shared care for the IBD patient, and Jacqui Fletcher gave tips for primary care clinicians on the best approaches to managing IBD patients.
     
    The video production for this presentation was funded by Emerge Health.

    Toxicity of immune checkpoint inhibitors: Immune related side effects

    Dr Rosalie Stephens is a medical oncologist at Auckland Hospital with a special interest in treating melanoma and is a Trustee on the board of Melanoma NZ. In this video podcast Dr Stephens describes some of the side effects produced by the immune checkpoint inhibitor class of treatments.
     

    Asthma & Respiratory Foundation NZ Adult Asthma Guidelines: A Quick Reference Guide

    Presentation by:
    Professor Richard Beasley
    Physician at Wellington Regional Hospital, Director of the Medical Research Institute of New Zealand, and Professor of Medicine at Victoria University of Wellington. Adjunct Professor at the University of Otago and Visiting Professor, University of Southampton, United Kingdom.

    In this video podcast Professor Richard Beasley provides an outline of the NZ Adult Asthma Guidelines published in November 2016. The purpose of the Asthma Foundation of New Zealand Quick Reference Guide is to provide simple, practical, evidence-based recommendations for the diagnosis, assessment and management of asthma in adults in a quick reference format. Professor Beasley also focuses on the changes to the guidelines since they were last update in 2002.

    The Future of Immuno-Oncology

    Dr Robert Weinkove, Consultant Haematologist at Wellington Blood and Cancer Centre and Clinical Director at Malaghan Institute of Medical Research discusses the future of immuno-oncology. He outlines new treatment modalities and new combinations of immuno-oncology agents with conventional treatments.
     

    ALK Mutated Lung Cancer: A Rare Subtype of Non-Small Cell Lung Cancer

    Dr Gareth Rivalland, Medical Oncologist, discusses ALK mutated lung cancer. He describes its characteristics, diagnosis and staging, and various treatment options.

     

    Gareth is a Medical Oncologist specialising in thoracic and skin cancers at Auckland City Hospital and Harbour Cancer Centre in Auckland.

    Curing Hepatitis C in Primary Care

    GPCME 2019 - Rotorua
    Saturday June 22, 2019

    Presentation by:
    Dr Alex Lampen-Smith
    Gastroenterologist and Hepatologist at the Bay of Plenty District Health Board, and Clinical Director of the Hepatitis Foundation of New Zealand.

    In this breakfast symposium held at GPCME 2019, Dr Alex Lampen-Smith presented risk factors associated with Hepatitis C (HCV), barriers to identifying the disease and pre-treatment assessment of patients with HCV.  She also introduced the funded HCV therapy Maviret® and discussed its use, illustrated by a number of case studies.

    The video production for this presentation was funded by Abbvie.

    What Can I Do If My Patient Asks Me About Help With Weight Loss?

    This video podcast is from a recent GPCME Rotorua presentation given by endocrinologist Dr Ole Schmiedel who outlines a solution-focused approach to medical weight management, focusing on improvement of obesity-related complications rather than on weight itself. The aim of this session was to provide practical knowledge on how to approach weight management, with several individual cases provided as examples of the various approaches.
     

    Simplifying COPD Treatment – Associate Professor Rob Young

    Simplifying COPD Treatment

    GPCME, South

    Saturday August 10, 2019

    Presentation by:
    Associate Professor Robert Young
    Consultant Physician, Auckland Hospital

    In this Breakfast Symposium, Associate Professor Rob Young discusses the diagnosis of COPD and simplifying treatment in the New Zealand context. He also covers the benefits of dual bronchodilation, the place of inhaled corticosteroids and non-pharmacological treatment.

    Insulin initiation, titration and escalation: A practical guide for busy clinicians in primary care

    Webinar - October 2019

    Presentation by:
    Carl Peters
    Endocrinologist, North Shore Hospital

    In this webinar, Dr Carl Peters provided clinicians with a practical guide to the use of insulin in patients with type 2 diabetes mellitus.

    An Overview of Immunotherapy Treatment options for Urothelial Carcinoma

    Dr Alvin Tan, Medical Oncologist, discusses immunotherapy treatments in the metastatic urothelial setting in NZ.

    Alvin is a consultant medical oncologist specialising in genito-urinary cancers at Waikato Hospital and Braemar Hospital in Hamilton.

    Immuno-Oncology Treatment for Urothelial and Renal Cancer

    Speaker Alvin Tan, hosted by Steve Holliday

    In this recording of a live webcast event held in May 2020,  Dr Alvin Tan addressed an audience of NZ healthcare professionals on immuno-oncology in urothelial and renal cancer using case studies to demonstrate recent advances in this fascinating and fast-developing field.

    Alvin is a consultant medical oncologist specialising in genito-urinary cancers at Waikato Hospital and Braemar Hospital in Hamilton.
     

    Why are we weighting? Let’s start treating obesity

    Associate Professor Rinki Murphy

    GORD – How to Optimise Management

    Presented by Gastroenterologist Alasdair Patrick

    Immuno-Oncology Treatment for Colorectal Cancer

    Speaker Dr Dragan Damianovich.

    In this recording of a live webcast event held in July 2020,  Dr Damianovich addressed an audience of health professionals on developments in immuno-oncology in colorectal cancer. Dragan also presented updates from the recent virtual ASCO20 Conference.

    Dr Dragan Damianovich, MD (Zagreb) FRACP, has been a consultant Medical Oncologist at Auckland Hospital since 2006 and at Auckland Oncology since 2008. He is also the expert contributor to Colorectal Oncology Research Review. Dragan is also a member of the Australian Gastrointestinal Trials Group (AGITG), the American Society of Clinical Oncology (ASCO), the European Society of Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC).

     

    Extended Prevention of Recurrent VTE

    Speaker: Dr Gordon Royle

    In this recording of a live webcast event held in August 2020, Dr Royle addressed an audience of GPs and nurse practitioners on extended prevention of recurrent venous thromboembolism in primary care with a focus on the recommendations in the THANZ 2019 VTE Guidelines.

    Gordon Royle is a graduate of Otago Medical School. After moving to Auckland he undertook a Masters in Molecular Biology, and went on to train in Haematology. For the last 19 years he has been working as a Haematologist and researcher at Middlemore Hospital, and is a senior lecturer at Auckland University's School of Medicine. A particular interest is Coagulation Haematology. His clinical research experience includes the role of PI in several new oral anticoagulant trials. Prior research experience includes seven years' molecular biology in the USA including two years at The Salk Institute.

    The Elimin8 Educational Series on Hepatitis C - Benefits of a Cure

    This is the first in a series of audio podcasts on the elimination of Hepatitis C in NZ.

    In this podcast Assoc Professor Catherine Stedman discusses the benefits of curing Hepatitis C.

    We also hear from a patient about their personal experience of living with, and being cured of, the Hepatitis C virus.

    Associate Professor Stedman is a specialist Gastroenterologist and Hepatologist at Christchurch Hospital, and also works as a Clinical Senior Lecturer for the University of Otago where she convenes medical student gastroenterology teaching.

    Her field of research is liver disease and pharmacology, focusing on hepatitis C and autoimmune liver diseases. Her published papers in hepatitis C epidemiology have influenced global understanding of chronic hepatitis C epidemiology including government and Ministry of Health understanding and approach to hepatitis C treatment strategies.

    The audio production for this presentation was funded by Abbvie.  
     

    The Elimin8 Educational Series on Hepatitis C - Testing and Treatment

    This is the second in a series of audio podcasts on the elimination of Hepatitis C in NZ.    

    In this podcast we hear from Dr Homie Razavi, Associate Professor Catherine Stedman and Judith McLaughlin, Hepatitis Nurse Specialist, on testing and treating the Hepatitis C virus. We also hear from a patient about their personal experience of being diagnosed with Hepatitis C.

    The audio production for this presentation was funded by Abbvie.  
     

    The Elimin8 Educational Series on Hepatitis C - Treatment in Primary Care

    This is the third in a series of audio podcasts on the elimination of Hepatitis C in NZ. 

    In this podcast we hear from Dr John Cameron, a GP based in Auckland, who moves through the Hepatitis C Care Cascade using his own patient case study. 

    In this very informative interview Dr Cameron provides practical, down to earth advice to his GP colleagues on how to approach their patients with HCV, and how to help them deal with the stigma associated with this disease.

    The audio production for this presentation was funded by Abbvie.  
     

    The ElimIn8 Educational Series on Hepatitis C - A virus we can cure

    Welcome to the ElimIn8 Educational Series on Hepatitis C - A virus we can cure*.

    The series consists of three, short audio podcasts where health professionals discuss the role of primary care in  the elimination of Hepatitis C from New Zealand.

    *Cure means no detectable HCV RNA is found in a blood test taken 12 weeks after treatment has finished.

    The audio production for this presentation was funded by Abbvie.